Eton Pharmaceuticals, Inc. (ETON)
29.55
-1.47
(-4.74%)
USD |
NASDAQ |
May 08, 14:22
Eton Pharmaceuticals Research and Development Expense (Annual) : 7.765M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amicus Therapeutics, Inc. (DELISTED) | 135.84M |
| Ovid Therapeutics, Inc. | 25.38M |
| Rhythm Pharmaceuticals, Inc. | 166.90M |
| Vir Biotechnology, Inc. | 432.80M |
| Sensei Biotherapeutics, Inc. | 10.96M |